相似文献
1
Assocation of endostatin D104N with leukemia.
Kaohsiung J Med Sci. 2003 Jan;19(1):1-5. doi: 10.1016/s1607-551x(09)70440-1.
2
Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in prostate [corrected] cancer.
Dis Markers. 2005;21(1):37-41. doi: 10.1155/2005/650109.
3
A high risk of osteosarcoma in individuals who are homozygous for the p.D104N in endostatin.
Sci Rep. 2015 Nov 6;5:16392. doi: 10.1038/srep16392.
4
Genotyping and functional analysis of the D104N variant of human endostatin.
Cancer Biol Ther. 2004 Dec;3(12):1298-303. doi: 10.4161/cbt.3.12.1453. Epub 2004 Dec 16.
5
A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.
Cancer Res. 2001 Oct 15;61(20):7375-8.
6
Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
BMC Cancer. 2007 Jun 22;7:107. doi: 10.1186/1471-2407-7-107.
7
Polymorphism analysis of CYP3A5 in myeloid leukemia.
Oncol Rep. 2002 Mar-Apr;9(2):327-9.
8
Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study.
Int J Cancer. 2009 Sep 1;125(5):1143-6. doi: 10.1002/ijc.24423.
9
Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors.
Clinics (Sao Paulo). 2012;67(2):95-8. doi: 10.6061/clinics/2012(02)02.
10
Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia.
Hematology. 2008 Apr;13(2):95-100. doi: 10.1179/102453308X315898.
引用本文的文献
1
Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors.
Clinics (Sao Paulo). 2012;67(2):95-8. doi: 10.6061/clinics/2012(02)02.
2
Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
BMC Cancer. 2007 Jun 22;7:107. doi: 10.1186/1471-2407-7-107.
本文引用的文献
1
Two genetic hits (more or less) to cancer.
Nat Rev Cancer. 2001 Nov;1(2):157-62. doi: 10.1038/35101031.
2
Polymorphism analysis of CYP3A5 in myeloid leukemia.
Oncol Rep. 2002 Mar-Apr;9(2):327-9.
3
Angiogenesis-dependent diseases.
Semin Oncol. 2001 Dec;28(6):536-42. doi: 10.1016/s0093-7754(01)90021-1.
4
A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.
Cancer Res. 2001 Oct 15;61(20):7375-8.
5
The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens.
Biochim Biophys Acta. 2001;1471(2):C1-10. doi: 10.1016/s0304-419x(00)00021-4.
6
Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Mol Ther. 2001 Feb;3(2):186-96. doi: 10.1006/mthe.2000.0243.
7
8
Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model.
Cancer Res. 2000 Aug 15;60(16):4362-5.
9
Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis.
Blood. 2000 Jun 1;95(11):3403-11.
10
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Blood. 2000 Apr 15;95(8):2637-44.
Zotero 插件